Clinical Trials Browser

Phase 2/3 × Endometrial Adenocarcinoma × Paclitaxel × Clear all

NCT02065687 2021-09-30

Paclitaxel and Carboplatin With or Without Metformin Hydrochloride in Treating Patients With Stage III, IV, or Recurrent Endometrial Cancer

Phase 2/3 Unknown

469 enrolled 16 charts

Endometrial Adenocarcinoma